|
FY2017
12 months to Dec 31, 2017
|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
|
|---|---|---|---|
| Revenue | |||
| Operating expenses: | |||
| Research and development | |||
| General and administrative | |||
| Litigation | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other-than-temporary impairment loss | |||
| Interest income, net | |||
| Other (expenses) income, net | |||
| Loss before income taxes | |||
| Benefit for income taxes | |||
| Net loss | |||
| Deemed dividend upon issuance of convertible preferred stock, non-cash | |||
| Net loss per share, basic and diluted (usd per share) | |||
| Weighted average common shares outstanding, basic and diluted (in shares) |
Loading...
